Skip to content

Adherence to, knowledge and beliefs about drugs used to reduce phosphate absorption in dialysis patients

Interventional study to improve adherence to phosphate binder treatment in dialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52852596
Enrollment
122
Registered
2019-04-11
Start date
2017-05-22
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney disease requiring dialysis Urological and Genital Diseases

Interventions

Patients included in the study received a single half-hour one-to-one pharmacist-led education and personalized counselling session. A semi-structured counselling guide was used in the session. An edu

Sponsors

The Hospital Pharmacies Enterprise, Sout Eastern Norway
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age>18 years 2. Receiving chronic dialysis two to four times a week for at least five months 3. Using at least one self-administered phosphate binder 4. Able to speak, read and write Norwegian 5. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Life expectancy < 5 months

Design outcomes

Primary

MeasureTime frame
Change in the proportion of patients with serum phosphate below 1.80 mmol/L. Serum phosphate levels for five months prior to the intervention, and five months after were drawn from the medical records for included patients.

Secondary

MeasureTime frame
Change in the patient's knowledge, beliefs and adherence after the intervention measured by completion of questionnaires: 'Patient Knowledge' 'Medication Adherence Report Scale' 'Beliefs about Medicines Questionnaire' The participants were asked to answer the questionnaires twice; at the time of inclusion and 3 - 4 weeks after the intervention.

Countries

Norway

Contacts

Public ContactBodil Jahren Hjemås
bodil.jahren.hjemas@sykehusapotekene.no+4767960302

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 3, 2026